Oruka Therapeutics (ORKA) PT Raised to $130 at UBS as Stock Undervalued

July 1, 2026 9:21 AM

UBS analyst Michael Yee raised the price target on Oruka Therapeutics (NASDAQ: ORKA) to $130.00 (from $100.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found